HF
CLMT icon

HRT Financial’s Calumet Specialty Products CLMT Stock Holding History

HRT Financial’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-98,600
Closed -$1.96M – 3904
2025
Q4 		$1.96M Buy
+98,600
New +$1.9M 0.01% 1319

Other funds holding CLMT

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WDOM
Wasserstein Debt Opportunities Management New York $264M AUM 188.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Adams Asset Advisors Dallas, Texas $984M AUM 41.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HRT Financial's CLMT Position: Q2 2026 in Review

HRT Financial sold out of Calumet Specialty Products (CLMT) in Q2 2026, closing a stake of 118,290 shares — an estimated $4.25M sold.

HRT Financial first reported a position in CLMT in Q4 2021 and held it in 3 quarters. The position peaked at $4.25M in Q1 2026. 188 funds tracked by Wall St. Rank hold CLMT as of Q2 2026.

  • HRT Financial reported no remaining Calumet Specialty Products position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 118,290 Calumet Specialty Products shares in Q2 2026, an estimated $4.25M.
  • HRT Financial first reported a position in Calumet Specialty Products in Q4 2021 and held it in 3 quarters.
  • HRT Financial's Calumet Specialty Products position peaked at $4.25M in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.